Cancer incidence and mortality rates are higher in blacks for almost every kind of cancer. The cancer problem in rural blacks is compounded by a regional lack of cancer specialists and treatment. The Medical College of Virginia/Community Memorial Healthcenter Minority-Based (MCV/CMH M-CCOP) is designed to increase the availability of protocol-based cancer treatment and control research trials to the urban and rural minorities of Richmond and Southside Virginia. Greater than 48% of 720 selected new cancer cases at the MCV/CMH M-CCOP sites are minority, nearly all black. Approximately 82 new treatment and 320 cancer control patients will be entered on trial in Year One and more than 50% of those accruals will be minorities. Organizational and operational plans are presented which will provide the structure for the effective implementation of multidisciplinary research. Community acceptance of new programs is facilitated by advisors from the black community who have provided enthusiastic support. This application will emphasize the unique urban and rural populations available to the M-CCOP, the history of extensive participation in clinical research by the Medical College of Virginia Hospitals (MCV), and the recent MCV initiatives in cancer outreach conducted at the rural M-CCOP site, the Community Memorial Health center (CMH) in South Hill, Virginia. The MCV/CMH M-CCO will collaborate with 3 research bases. MCVH has a longstanding relationship with NSABP and has won awards based onaccrual and quality of data management. The CALB affiliation, through the University of North Carolina at Chapel Hill, began in April 1989. We have a new affiliation with the Fox Chase Cancer Center (FCCC) that provides high quality cancer control protocols. We address patient education and special issues of the rural and urban black population in this application. Strategies to increase minority participation in clinical research include: a) involvement of the Cancer Rehabilitation/Continuing Care home health nurses in protocol patient care, b) consent form reading level modification by the State Department of Adult Basic Education in Virginia, and c) collaboration with cancer control research bases to develop protocols feasible for the minority communities. In addition, the financial and staffing obstacles which could hinder research efforts are discussed along with strategies to overcome them. Finally, a method which measures accessibility to American College of Surgeons certified cancer programs by blacks and whites is demonstrated. A recent analysis shows rural blacks receive treatment at an ACOS facility half as frequently as urban whites. Implications of this analysis and potential for evaluating M-CCOP success are discussed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10CA052784-03S1
Application #
3558979
Study Section
Special Emphasis Panel (SRC (42))
Project Start
1990-09-01
Project End
1994-05-31
Budget Start
1993-06-01
Budget End
1994-05-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Himelstein, Andrew L; Foster, Jared C; Khatcheressian, James L et al. (2017) Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial. JAMA 317:48-58
Uy, Geoffrey L; Mandrekar, Sumithra J; Laumann, Kristina et al. (2017) A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001. Blood Adv 1:331-340
Ports, Katie A; Ayers, Antoinette; Crocker, Wayne et al. (2015) Community perceptions and utilization of a consumer health center. J Med Libr Assoc 103:35-9
Rafie, Carlin; Ayers, Antoinette; Cadet, Debbie et al. (2015) Reaching Hard to Reach Populations with Hard to Communicate Messages: Efficacy of a Breast Health Research Champion Training Program. J Cancer Educ 30:599-606
Mosavel, Maghboeba; Rafie, Carlin; Cadet, Debbie L et al. (2012) Opportunities to reduce cancer barriers: community town halls and provider focus groups. J Cancer Educ 27:641-8
Bertagnolli, Monica M; Redston, Mark; Compton, Carolyn C et al. (2011) Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. J Clin Oncol 29:3153-62
Paschka, Peter; Marcucci, Guido; Ruppert, Amy S et al. (2008) Wilms'tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 26:4595-602
Silverman, Lewis R; McKenzie, David R; Peterson, Bercedis L et al. (2006) Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B. J Clin Oncol 24:3895-903
Lamont, Elizabeth B; Herndon 2nd, James E; Weeks, Jane C et al. (2006) Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst 98:1335-8
Halabi, Susan; Vogelzang, Nicholas J; Ou, San-San et al. (2006) Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies. J Urol 176:81-6

Showing the most recent 10 out of 22 publications